Post Reply
1-20 of 48
Latest news on the co. was two weeks back, where the grp report 1QFY14 results which were in line, with net profit of $1.4m (+318% y/y, -69% q/q) on revenue of $79.5m (+13% y/y, +3% q/q). Apart from being seasonally the slowest quarter, the sequential decline in earnings was largely due to a once-off fairvalue gain recognized in 4QFY13. The group?s topline was buoyed by a strong sales performance in its Hong Kong (+26%) and Australia (+16%) operations with S?pore (-2%) the only exception. Revenue for its retail segment rose 13% to $60.1m from growth in most markets, while wholesale revenue jumped 15% to $14.0m, largely driven by Hong Kong and Macau. Clinic revenue improved 6% to $4.5m. Gross margins was maintained at a healthy 51% and with operating expenses kept in check, operating profit soared 48%, translating to a stronger bottomline. During the quarter, the group added four and closed five outlets, taking its retail chain to 299 shops, comprising 250 company-operated and 49 franchisee outlets. The number of clinics (29) and medical centres (2) remained unchanged. Net gearing is a manageable 0.5x. Going forward, the group expects rising operating costs, especially retail rents to pose a challenge, while tipping its core business to remain profitable and cash flow positive. The group will also pursue other strategic opportunities for growth in new lines of business that complement its existing ones. At the current price, EYS trades at a forward 18x P/E, at the higher end of its TCM peers in HK and S?pore. Latest broker ratings as follows: CIMB upgrades to Neutral from U/p with TP $0.75
TRADITIONAL Chinese medicine retailer Eu Yan Sang International registered a 49 per cent fall to $4.7 million in net profit for the fourth quarter ended June 30 despite an 11 per cent rise in revenue to $77.3 million.
The fall in earnings was because of a 36 per cent drop to $4.5 million in fair value gain on investment properties
For the fiscal full year, net profit rose 11 per cent to $18.1 million, helped by substantially lower impairment costs.
Impairment costs totalled $9.2 million in fiscal 2012, including the writing-off of the equity investment in ASX-listed Healthzone Ltd.
OSKDMG and CIMB turning positive on stock with CIMB initiating Coverage with Buy call and OSKDMG adding the stock to its small-mid cap portfolio. - CIMB initiates Coverage with O/p Call and $0.89 TP. Note that leading TCM player EYS should be able to leverage on its strong brand name and grow the franchise in its Australian and Chinese segments. A turnaround is already taking place in Australia.
The recent JV in Chengdu should ensure the steady supply of quality herbs. Think that the group is well positioned to combat rising rental and raw material costs. Phase 1 capacity expansion plans are due to be completed in 2016 and this will more than double its existing capacity.
The Sichuan Neautus JV will also improve margins through lower raw material costs and sales of quality herbs at a later stage. In light of this, house nitiate coverage with an Outperform and target price of $0.89, based on 16.3x CY14 P/E (0.5 s.d. above its 5-year historical mean). A turnaround of its Australian and Chinese business segments is a potential re-rating catalyst - DMG small-mid cal specialists Terrence Wong says that he will be buying Eu Yan Sang, in DMG’s model portfolio, citing that Eu Yan Sang troubled Aussie subsidiary HealthLife, while still loss-making, Eu Yan Sang is on the mend and is expected to break even by FY15. In terms of valuation, its forward P/E of 16x is very reasonable compared to HK- listed Beijing Tong Ren Tang (8138 HK), which is going for 35x earnings.
新 加 坡 余 仁 生 网 站 被 黑 留 下 雾 霾 言 论 ....新 加 坡 讯 ， 新 加 坡 中 药 公 司 余 仁 生 的 网 站 今 天 早 上 被 黑 。
黑 客 在 被 黑 后 的 网 页 上 写 下 姓 名 为 “Bambu”， 上 面 写 道 ： “不 要 因 为 你 们 国 家 的 烟 雾 而 羞 辱 我 们 国 家 。 ”
黑 客 写 道 ： “你 们 不 应 该 因 为 空 气 污 染 单 是 指 责 印 尼 ， 应 该 指 责 风 ， 和 要 风 吹 向 你 们 国 家 的 人 。 ”
此 外 ， “Bambu”也 黑 掉 了 另 一 个 网 站 ineltronics.com。
余 仁 生 的 网 站 已 经 恢 复 正 常 。 ...Last Done: $0.765... 哎 呀 ， 都 是 你 的 错 ....
Eu Yan Sang's S$75m 5-yr notes carry a coupon rate of 4.10%
Eu Yan Sang International on Friday priced its S$75 million, 5-year
unsecured notes due June 6, 2018, at 100 per cent. The bonds will bear a
fixed coupon rate of 4.10% per annum. They are expected to be
issued on June 6, 2013. The issue attracted healthy interest, with order
book closing at S$350 million. (Source: Business Times)
...Last Done: $0.785...
Eu Yan Sang International on Thursday said it will form a 50-50 joint
venture (JV) with Chengdu-based Sichuan Neautus Traditional Chinese
Medicine Co Ltd, one of the largest exporters of high quality TCM herbs
from China. The JV is is expected to improve the group's margins through
lower costs of raw materials and stronger upward integration of its
supply chain, it said. The venture was entered into through its unit, Eu
Yan Sang (Hong Kong) Limited. The JV, called EYS NEAUTUS (Sichuan)
Company Limited, plans to set up a TCM processed herbs plant in China,
with an online traceability feature to trace herbs from sources. This
plant will cost RMB40 million (S$8 million) to build, it said. (Source:
Business Times) ...lst done: $0.760...
Eu Yan Sang International Ltd. announced that the Company will increase its investment in Healthzone Limited, to 19.9% of the share capital of HZL.
http://sgsharemarket.com/home/2011/06/singapore-company-highlights-07062011/
Don't get too bullish about this stock. And what it produces is simply mumbo jumbo. They tried to get the Chinese University of Hong Kong to synthesise their drugs and turn them into proper pharmaceutical compounds but never succeeded.
What do they call alternative medicine that works?
Medicine. (See Glaxo, Pfizer, Merck).
| Eu Yan Sang posts 13% fall in 2Q net profit to $4.1m |
Tags: Eu Yan Sang International
| WRITTEN BY THE EDGE |
| THURSDAY, 10 FEBRUARY 2011 17:57 |
Mainboard-listed Eu Yan Sang International, the the Traditional Chinese Medicine (TCM) and integrative healthcare provider, recorded a jump of 43% in its profit before tax to $7.8 million for its second financial quarter ended 31 December 2010 (2QFY2011). This came on the back of a 9% increase in revenue to $64 million. A one-off additional tax expense however brought a decrease of 13% to the group’s net profit to shareholders to $4.1 million. Net profit for 6 months ended 31 December 2010 (1HFY2011) stayed flat with a dip of just 1.6% to $8.2 million.
|
EuYanSang has reached the downside target at 75 cents today . Breaking the near term support at 73.5 cents would go down to 65 cents .
heavenade ( Date: 10-Jan-2011 12:39) Posted:
thanks alot!
Bintang ( Date: 10-Jan-2011 12:25) Posted:
| It would go down to 75 cents which is the only near term support |
|
|
|
January 10 --
The Shanghai Composite Index dropped 1.66 percent or 46.99 points to close at 2,791.81 points today on transaction value of 110.80 billion yuan.
The Shenzhen Component Index decreased 1.93 percent or 242.78 points to close at 12,331.16 points today on transaction value of 86.44 billion yuan.
Almost all the sectors ended with declines today.
The healthcare sector was one of the biggest laggards today. Wuhan Humanwell Healthcare (Group) (600079, 22.54, -9.15%) dropped almost by its daily limit. Guangzhou Pharmaceutical (600332, 22.66, -7.05%) and Zhejiang Xianju Pharmaceutical (002332, 19.00, -7.09%) fell more than 7 percent. A total of 138 million restricted shares of Zhejiang Xianju Pharmaceutical will be made tradable on January 12. According to a report by Beijing Evening News, the national essential drug system is to be completed by the end of 2011.
| 1. | Date of notice to issuer * | 10-01-2011 |
| 2. | Name of Director * | Dr Jennifer Gek Choo Lee |
| 3. | Please tick one or more appropriate box(es): * |
| |
Notice of a Director's (including a director who is a substantial
shareholder) Interest and Change in Interest. [Please complete Part II
and IV]
|
| 1. | Date of change of Interest | 06-01-2011 |
| 2. | Name of Registered Holder | Dr Jennifer Gek Choo Lee |
| 3. | Circumstance(s) giving rise to the interest or change in interest | # Others |
| | # Please specify details |
|
Acceptance of share options granted under the Eu Yan Sang Employee Share Option Scheme 2006.
|
|
| 4. | Information relating to shares held in the name of the Registered Holder |
| |
| No. of Options held before the change | 156,000 |
| As a percentage of issued share capital | 0.035 % |
| No. of Options which are subject of this notice | 120,000 |
| As a percentage of issued share capital | 0.027 % |
| Amount of consideration (excluding brokerage and stamp duties) per share paid or received | 0 |
| No. of Options held after the change | 276,000 |
| As a percentage of issued share capital | 0.063 % | |
| 1. | Date of change of Interest | 07-01-2011 |
| 2. | Name of Registered Holder | Malcolm Man-Chung Au |
| 3. | Circumstance(s) giving rise to the interest or change in interest | # Others |
| | # Please specify details |
|
Acceptance of share options granted under the Eu Yan Sang Employee Share Option Scheme 2006.
|
|
| 4. | Information relating to shares held in the name of the Registered Holder |
| |
| No. of Options held before the change | 60,000 |
| As a percentage of issued share capital | 0.014 % |
| No. of Options which are subject of this notice | 120,000 |
| As a percentage of issued share capital | 0.027 % |
| Amount of consideration (excluding brokerage and stamp duties) per share paid or received | 0 |
| No. of Options held after the change | 180,000 |
| As a percentage of issued share capital | 0.041 % | |
thanks alot!
Bintang ( Date: 10-Jan-2011 12:25) Posted:
It would go down to 75 cents which is the only near term support .
heavenade ( Date: 10-Jan-2011 12:15) Posted:
| im holding some positions @ 86.5c, is it sensible to cut loss now?
|
|
|
|
It would go down to 75 cents which is the only near term support .
heavenade ( Date: 10-Jan-2011 12:15) Posted:
im holding some positions @ 86.5c, is it sensible to cut loss now?
Bintang ( Date: 10-Jan-2011 12:08) Posted:
|
|
|
im holding some positions @ 86.5c, is it sensible to cut loss now?
Bintang ( Date: 10-Jan-2011 12:08) Posted:
|
It is in the downtrend .
Bintang ( Date: 19-Nov-2010 20:07) Posted:
| If EuYanSang would go up again to hit the old high with small volume , then it would confirm the completion of the top formation |
|
|
|
It is in the downtrend .
Bintang ( Date: 19-Nov-2010 20:07) Posted:
If EuYanSang would go up again to hit the old high with small volume , then it would confirm the completion of the top formation .
Bintang ( Date: 15-Oct-2010 13:09) Posted:
| Eu Yan Sang has been in its up trend since late August 2010 . Its monthly RSI has gone into over-bought position at the same time . Breaking 87.5 cents would send EuYanSang to hit another new high at $1.05 . |
|
|
|
can some seniors assist to shine some light on this counter?
